Healthcare Global Enterprises Ltd.
-
NSE: HCG
-
BSE: 539787
-
Q
-
V
-
T
Quality Score
Medium Financial StrengthValuation Score
Expensive ValuationTechnical Score
Technically NeutralBroker average target upside %
8.00 %
Below industry Median
TTM PE Ratio
149.90
Market Leader
Price to Book Ratio
5.10
Above industry Median
Operating Revenues Qtr Cr
441.70 Cr
Above industry Median
Net Profit Qtr Cr
8.40 Cr
Below industry Median
RSI
65.60
RSI is mid-range
MFI
69.30
MFI is mid-range
MACD
10.50
MACD above Signal and Center
MACD Signal Line
10.30
MACD above Signal and Center
30Day SMA Rs
294.60 Rs
Price above SMA 294.55
50Day SMA Rs
283.20 Rs
Price above SMA 283.18
100Day SMA Rs
281.20 Rs
Price above SMA 281.23
200Day SMA Rs
284.80 Rs
Price above SMA 284.76
Promoter holding %
71.37
Promoter holding decreased by 0.0100%.
FII holding current Qtr %
6.37
FII holdings fell by 0.81%
MF holding current Qtr %
3.87
MF holdings rise by 0.86%
Institutions holding %
11.90
Institutions holding increased by 0.3100%.
Broker Average Rating
4.60
Broker Average Rating
Broker Covering stock
6.00
6 Broker Covering stock
Broker 1Year total
19.00
19 Broker 1Year total
Broker 6M Reco downgrade
2.00
2 Broker 6M Reco downgrade
Broker 6M Reco upgrade
0.00
0 Broker 6M Reco upgrade
Broker 6M Target downgrade
4.00
4 Broker 6M Target downgrade
Broker 6M Target upgrade
2.00
2 Broker 6M Target upgrade
Momentum score
58.74
Technically Neutral
Valuation score
19.67
Expensive Valuation
Quality score
53.61
Medium Financial Strength
-
- 2023-06-03T10:24:42+00:00
HealthCare Global Enterprises Ltd - 539787 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dr B S Ajaikumar
Read More -
- 2023-06-03T10:14:57+00:00
HealthCare Global Enterprises Ltd - 539787 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aceso Company Pte Ltd
Read More -
- 2023-06-02T05:25:06+00:00
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the Earnings Call held on May 26, 2023, with Analysts/Investors to discuss the audited Financial Results of the quarter and year ended March 31, 2023.
Read More -
- 2023-05-29T03:54:55+00:00
HealthCare Global Enterprises Ltd - 539787 - Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Business Update
Read More -
- 2023-05-27T08:18:01+00:00
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement of Postal Ballot Notice dated May 26, 2023 of HealthCare Global Enterprises Limited ('the Company')
Read More -
- 2023-05-27T08:12:30+00:00
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement of Audited Financial Results of HealthCare Global Enterprises Limited ('the Company') for the quarter and year ended March 31, 2023
Read More -
- 2023-05-27T08:10:02+00:00
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement of Audited Financial Results of HealthCare Global Enterprises Limited ('the Company') for the quarter and year ended March 31, 2023
Read More -
- 2023-05-27T08:09:17+00:00
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement of Audited Financial Results of HealthCare Global Enterprises Limited ('the Company') for the quarter and year ended March 31, 2023
Read More -
- 2023-05-26T15:16:50+00:00
HealthCare Global Enterprises Ltd - 539787 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the year ended March 31, 2023 as per Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Read More -
- 2023-05-26T13:29:04+00:00
HealthCare Global Enterprises Ltd - 539787 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Postal Ballot Notice (only through the remote e-voting process) Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Read More -
- 2023-05-26T11:07:02+00:00
HealthCare Global Enterprises Ltd - 539787 - Earnings Call Recording
Earnings Call held with Analysts/Investors to discuss the Audited Financial Results of the quarter and year ended March 31, 2023
Read More -
- 2023-05-25T14:39:33+00:00
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor presentation on financial results for the quarter and year ended March 31, 2023.
Read More -
- 2023-05-25T14:35:23+00:00
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release on financial results for the quarter and year ended march 31, 2023.
Read More -
- 2023-05-25T14:08:51+00:00
HealthCare Global Enterprises Ltd - 539787 - Announcement Under Regulation 30 Of SEBI LODR
Disclosure of Related Party Transactions for the half year ended March 31, 2023 as per Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Read More -
- 2023-05-25T12:59:19+00:00
HealthCare Global Enterprises Ltd - 539787 - Announcement under Regulation 30 (LODR)-Change in Directorate
Board of Directors of the Company at their meeting held on Thursday, May 25, 2023, on the recommendation of the Nomination and Remuneration Committee, has considered and approved the appointment of Mr. Rajiv Maliwal (DIN: 00869035), as an Independent Director (Additional Director in terms of Section 161 of the Companies Act, 2013) for a term of three (3) years with effect from May 25, 2023, subject to the approval of shareholders of the Company and that he shall not be liable to retire by rotation.
Read More -
- 2023-05-25T12:47:15+00:00
HealthCare Global Enterprises Ltd - 539787 - Board Meeting Outcome for Results And Issue & Allotment Of Equity Shares
Board of Directors of the Company, at their meeting held on this day, May 25, 2023, inter alia, has considered and approved Audited Financial Results (Standalone and Consolidated) of the Company for the year ended March 31, 2023 together with Auditor's Report thereon; including Issue & allotment of Equity Shares
Read More -
- 2023-05-25T12:40:01+00:00
HealthCare Global Enterprises Ltd - 539787 - Results- Financial Results For March 31, 2023
Board of Directors of the Company, at their meeting held on this day, May 25, 2023, inter alia, has considered and approved Audited Financial Results.
Read More -
- 2023-05-12T11:20:23+00:00
HealthCare Global Enterprises Ltd - 539787 - Intimation Of Earnings Call To Discuss The Audited Financial Results Of Healthcare Global Enterprises Limited
An Earnings Conference Call has been scheduled on Friday, May 26, 2023, at 9.30 am (IST), to discuss the Audited Financial Results of the Company.
Read More -
- 2023-05-12T07:05:37+00:00
HealthCare Global Enterprises Ltd - 539787 - Board Meeting Intimation for Intimation Of Board Meeting
Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/05/2023 ,inter alia, to consider and approve and take on record the Audited Financial Results (both Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2023.
Read More -
- 2023-04-27T11:24:49+00:00
HealthCare Global Enterprises Ltd - 539787 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyHealthCare Global Enterprises Ltd 2CIN NO.L15200KA1998PLC023489 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 113.02 4Highest Credit Rating during the previous FY A+ 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)ICRA LIMITED 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Sunu Manuel Designation: Company Secretary and Compliance Officer EmailId: sunumanuel@hcgel.com Name of the Chief Financial Officer: Srinivasa V Raghvan Designation: Chief Financial Officer EmailId: srini.raghavan@hcgel.com Date: 27/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Read More
| Ex-date | Dividend Amount | Dividend Type | Record Date |
|---|
Bonus History
Adani Ports & Special Economic Zone Ltd. has not announced any bonus since Jan 1, 2000.
Check out stocks with top dividendAdani Ports & Special Economic Zone Ltd. has split the face value 1 time since Sept. 23, 2010. Adani Ports & Special Economic Zone Ltd. had last split the face value of its shares from Rs 10 to Rs 2 in 2016.The share has been quoting on an ex-split basis from Sept. 23, 2010.
| Ex-date | Old FV | New FV | Record Date |
|---|---|---|---|
| Sept. 23, 2010 | 10 | FINAL | Sept. 24, 2010 |